Udo Oppermann

17PUBLICATIONS
132CO-AUTHORS
Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Obstetrics and gynaecologyInnate immunityGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Aug 24, 2026
Inhibition of cyclin-dependent kinase 8 modulates chondrocyte transition to hypertrophy and provides in vivo protection against spontaneous osteoarthritis.

|Aug 12, 2026
Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease.

|Jul 31, 2025
A systems-based approach to uterine fibroids identifies differential splicing associated with abnormal uterine bleeding.

Chen-Yi Wang, Martin Philpott, Darragh P O'Brien

|Dec 20, 2023
Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination.

Clement Twumasi, Sally Moore, Ross Sadler

|Nov 29, 2021
First-in-Class Inhibitors of the Ribosomal Oxygenase MINA53.

Radosław P Nowak, Anthony Tumber, Eline Hendrix

|Aug 26, 2021
Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis.

Thomas T Tapmeier, Nilufer Rahmioglu, Jianghai Lin

Pageof 3

Frequent Collaborators

4 joint publications

Krina T Zondervan

3 joint publications

Thomas Tapmeier

3 joint publications

Christian M Becker

3 joint publications

Cemsel Bafligil